Financial News
Latest News about GLTO
Recent news which mentions GLTO
Crude Oil Down 2%; Home Depot Posts Upbeat Earnings
August 15, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
August 15, 2023
From Benzinga
Dow Falls Over 200 Points; US Retail Sales Top Expectations
August 15, 2023
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 15, 2023
From Benzinga
From Benzinga
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 25, 2023
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
November 04, 2022
From Benzinga
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
September 30, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 29, 2022
From Benzinga
Galecto's Myelofibrosis Candidate Reduces Bone Marrow Fibrosis
September 29, 2022
Tickers
GLTO
From Benzinga
From Benzinga
69 Biggest Movers From Friday
June 06, 2022
From Benzinga
Executives Buy Over $2.2M Of 3 Penny Stocks
March 24, 2022
From Benzinga
63 Biggest Movers From Friday
December 20, 2021
From Benzinga
Galecto To Test GB1211 Combined with Roche's Tecentriq In First Line Lung Cancer Setting
November 02, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
